Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Aminopterin in Treating Patients With Refractory Leukemia

ClinicalTrials.gov ID: NCT00003305

Public ClinicalTrials.gov record NCT00003305. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 11:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Aminopterin in Adults and Children With Refractory Acute Leukemia Grant Application Title: A Phase II Trial of Aminopterin in Acute Leukemia

Study identification

NCT ID
NCT00003305
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genzyme, a Sanofi Company
Industry
Enrollment
75 participants

Conditions and interventions

Conditions

Interventions

  • aminopterin Drug
  • leucovorin calcium Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 1997
Primary completion
Not listed
Completion
Aug 31, 2007
Last update posted
Jan 5, 2014

1997 – 2007

United States locations

U.S. sites
14
U.S. states
9
U.S. cities
13
Facility City State ZIP Site status
Advanced Urology Medical Center Anaheim California 92801
South Coast Urological Medical Group Laguana Hills California 92653
Urology Specialists, P.C. Waterbury Connecticut 06708
Barzell, Whitmore, Treiman and Dunne - The Urology Treatment Center Sarasota Florida 34239
University of Chicago Cancer Research Center Chicago Illinois 60637
206 Research Associates Greenbelt Maryland 20770
Mid Atlantic Clinical Research Rockville Maryland 20850
Cancer Institute of New Jersey New Brunswick New Jersey 08901
Medical & Clinical Research Associates, LLC Bay Shore New York 11706
Herbert Irving Comprehensive Cancer Center New York New York 10032
Medical City Dallas Hospital Dallas Texas 75230
Urology Centers of North Texas Dallas Texas 75231
Urology San Antonio Research San Antonio Texas 78229
Children's Hospital and Regional Medical Center - Seattle Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 5, 2014 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003305 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →